NASDAQ$BIOLQ

Biolase Inc · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Briefing

Reported record consumable sales as total second quarter revenue increased 17% year over year.

BIOLASE reported a 17% year-over-year increase in total revenue, reaching $14.3 million, the highest quarterly revenue since Q4 2015. Consumable sales also hit a record $4.1 million, up 36% year-over-year. The company is implementing cost-saving initiatives expected to result in $5 to $6 million in annualized savings beginning in Q3.

  • Total revenue increased by 17% year-over-year to $14.3 million, marking the highest quarterly revenue since Q4 2015.
  • Consumable sales reached a record $4.1 million, a 36% increase year-over-year.
  • Approximately 69% of U.S. Waterlase sales came from new customers, with about one-third from dental specialists.
  • Gross margin improved by 100 basis points to 43%.

Headline financials

Total Revenue

$14.3M

Previous: $12.2M+16.8%
EPS (adj)

-$26.14

Previous: -$91.98+71.6%
Capital Expenditures

$357K

Previous: $274K+30.3%
Free Cash Flow

-$3.92M

Previous: -$6.89M+43.1%
Net Income

-$4.9M

Previous: -$5.6M+12.5%
Operating Income

-$3.9M

Previous: -$5.1M+23.5%
Gross Profit

$6.12M

Previous: $5.14M+19.0%
Cash & Equivalents

$6.93M

Previous: $19.5M-64.5%
Total Assets

$39.6M

Previous: $50.9M-22.1%
Stock-Based Comp

$84K

Previous: $891K-90.6%

Revenue & EPS history

Biolase · Revenue · Quarterly

$14.3M

Q2 2023+16.8%vs Q2 2022
Beat estimate in 7 of 13 quarters(54%)
ActualEstimate

Revenue by segment

Biolase · $8.8M total across 2 segments · Q2 2023

  • US Laser Revenue
    $6.3M+14.5%
  • International Laser Revenue
    $2.5M

Forward guidance

BIOLASE expects revenue for the second half of the year to be 15-20% higher than the comparable period a year ago and expects to achieve positive adjusted EBITDA results for the second half of 2023.

Tailwinds

  • Revenue for the second half of the year is expected to be 15-20% higher than the comparable period a year ago.
  • The company expects to achieve positive adjusted EBITDA results for the second half of 2023.
  • Cost-saving initiatives are expected to result in additional annualized savings of $5 to $6 million beginning in the third quarter.
  • Improving gross margins.
  • Continued revenue growth.

Headwinds

  • Subject to market dynamics that include pressure on the finances of dentists.
  • Continuing migration to dental service organizations.
  • Still a challenging environment in international markets.
  • Macroeconomic hurdles during the quarter.
  • Uncertainty of customer acceptance of new product offerings and market changes

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

-3.0%

Avg return

Earnings day

-6.6%

Avg return

5 days after

-13.5%

Avg return

30 days after

41%

24 / 58 earnings

Positive

+25.4%

Q2 2021

Best reaction

-45.7%

Q1 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2024-18.9%-9.9%+26.1%
Q2 2024+7.8%-10.0%-30.0%
Q1 2024+1.8%-10.8%-21.9%
Q4 2024+20.3%+7.5%-6.8%
Q3 2023-22.0%-17.3%-23.4%
Q2 2023-19.5%-6.2%-50.2%
Q1 2023-6.7%-15.4%-17.4%
Q4 2022-10.8%-24.8%-43.8%
Q3 2022+16.3%+27.7%-49.2%
Q2 2022-1.1%-5.3%-33.6%
Q1 2022+0.0%-2.0%-47.1%
Q4 2021+2.9%+4.1%-9.3%
Q3 2021-8.2%-17.9%-34.5%
Q2 2021+25.4%+5.7%+10.0%
Q1 2021-1.2%-1.5%-10.8%
Q3 2020-3.3%-10.4%-0.8%
Q2 2020-2.4%-4.7%-28.9%
Q1 2020-45.7%-49.0%-6.0%
Q4 2019-22.4%-52.1%-7.3%
Q3 2019-5.8%+6.3%+2.9%
Q2 2019-7.7%-12.3%-36.1%
Q1 2019+2.5%-8.4%-13.9%
Q4 2018-16.5%-18.0%-21.6%
Q3 2018-9.3%-9.3%-27.9%
Q2 2018+9.5%+29.9%+60.6%
Q1 2018-2.4%+1.1%-13.1%
Q4 2017-4.1%-7.8%-36.7%
Q3 2017+0.0%+0.0%-25.0%
Q2 2017-29.8%-32.3%-28.8%
Q1 2017-3.8%-3.0%-3.8%
Q4 2016-2.5%-4.2%+5.8%
Q3 2016+20.8%+20.1%+18.8%
Q2 2016+1.8%+12.4%+56.6%
Q1 2016-12.3%
Q4 2015-0.8%
Q3 2015+8.5%
Q2 2015+6.3%
Q1 2015+1.0%
Q4 2014-2.5%
Q3 2014-3.3%
Q2 2014+1.4%
Q1 2014-0.8%
Q4 2013+0.7%
Q3 2013-11.8%
Q2 2013-22.7%
Q1 2013+3.5%
Q4 2012+1.0%
Q3 2012+10.6%
Q2 2012-1.2%
Q1 2011+0.8%
Q1 2012+1.8%
Q4 2011+0.5%
Q4 2009+0.5%
Q3 2011+4.9%
Q3 2010+4.9%
Q2 2010-10.2%
Q4 2010-10.2%
Q2 2011-10.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro